Additional file 1 of Perceived helpfulness of treatment for generalized anxiety disorder: a World Mental Health Surveys report
Creators: name: Stein, Dan J.
name: Kazdin, Alan E.
name: Ruscio, Ayelet Meron
name: Chiu, Wai Tat
name: Sampson, Nancy A.
name: Ziobrowski, Hannah N.
name: Aguilar-Gaxiola, Sergio
name: Al-Hamzawi, Ali
name: Alonso, Jordi
name: Altwaijri, Yasmin
name: Bruffaerts, Ronny
name: Bunting, Brendan
name: de Girolamo, Giovanni
name: de Jonge, Peter
name: Degenhardt, Louisa
name: Gureje, Oye
name: Haro, Josep Maria
name: Harris, Meredith G.
name: Karam, Aimee
name: Karam, Elie G.
name: Kovess-Masfety, Viviane
name: Lee, Sing
name: Medina-Mora, Maria Elena
name: Moskalewicz, Jacek
name: Navarro-Mateu, Fernando
name: Nishi, Daisuke
name: Posada-Villa, José
name: Scott, Kate M.
name: Viana, Maria Carmen
name: Vigo, Daniel V.
name: Xavier, Miguel
name: Zarkov, Zahari
name: Kessler, Ronald C.
Publisher: name: figshare
Year: 2021
Subjects: subject: Medicine
subject: Pharmacology
subject: Biotechnology
subject: Cancer
subject: Mental Health
subject: Plant Biology
subject: FOS: Biological sciences

description: Additional file 1: Table 1. WMH sample characteristics by World Bank income categoriesa. Table 2. Conditional and cumulative probabilities of obtaining helpful treatment for generalized anxiety disorder after each professional seen, among respondents with lifetime DSM-5 generalized anxiety disorder who obtained treatment in low/middle-income and high-income countries. Table 3. Conditional and cumulative probabilities of persistence in help-seeking after previous unhelpful treatment, among respondents with lifetime DSM-5 generalized anxiety disorder who obtained treatment in low/middle-income and high-income countries. Table 4. Predictors of obtaining helpful treatment (person-level), among people with lifetime DSM-5 generalized anxiety disorder who obtained treatment. Table 5. Interactions between main effects and country income group to predict obtaining helpful treatment (person-level composite outcome) and the decomposed encounter-level outcomes of helpful treatment and persistence, among people with lifetime DSM-5 generalized anxiety disorder who obtained treatment. Table 6. (Low/middle-income countries): Predictors of obtaining helpful treatment (person-level composite outcome) and of the decomposed encounter-level outcomes of helpful treatment and persistence, among people with lifetime DSM-5 generalized anxiety disorder who obtained treatment. Table 7. (High-income countries): Predictors of obtaining helpful treatment (person-level composite outcome) and of the decomposed encounter-level outcomes of helpful treatment and persistence, among people with lifetime DSM-5 generalized anxiety disorder who obtained treatment. Table 8. Interactions between main effects and historical time to predict obtaining helpfulness of treatment (person-level composite outcome) and the decomposed encounter-level outcomes of helpful treatment and persistence, among people with lifetime DSM-5 generalized anxiety disorder who obtained treatment. Table 9. (Started GAD treatment in 2000 or later): Predictors of obtaining helpful treatment (person-level composite outcome) and of the decomposed encounter-level outcomes of helpful treatment and persistence, among people with lifetime DSM-5 generalized anxiety disorder who obtained treatment. Table 10. (Started GAD treatment 1990 to 1999): Predictors of obtaining helpful treatment (person-level composite outcome) and of the decomposed encounter-level outcomes of helpful treatment and persistence, among people with lifetime DSM-5 generalized anxiety disorder who obtained treatment.